[Protective effects of azithromycin on adriamycin-induced nephropathy with albumin overload in mice]

Zhongguo Ying Yong Sheng Li Xue Za Zhi. 2019 Nov;35(6):548-550. doi: 10.12047/j.cjap.5879.2019.120.
[Article in Chinese]

Abstract

Objective: To study the protective effects of azithromycin on renal damage induced by doxorubicin and albumin in mice.

Methods: Forty male BALB/c mice were randomly divided into blank control group (Ctrl group), renal damage model group (ADR+BSA group), azithromycin treated group (Azm group) and prednisone acetate positive control group (Pdn group) in accordance with random number table method. Mice in ADR+BSA, AZM and Pdn group were injected intravenously with 9.8 kg-1 doxorubicin five days a week, 10 kg-1 serum albumin was injected intraperitoneally, and normal saline was administered to the control group for 4 weeks to establish renal damage model. After that, AZM group was given daily. 62.5 kg-1 azithromycin was intragastrically administered. The Pdn group was given 12.5 kg-1 prednisone acetate daily, the other two groups were given the same amount of normal saline. After 6 weeks, the urine volume was collected and recorded for 24 hours to detected urine protein amount and endogenous creatinine clearance rate (Ccr). Serum biochemical indicators and serum immune factors were detected.

Results: Compared with the Ctrl group, the 24 h urine protein level of the ADR+BSA group was increased significantly (P<0.05), and the Ccr was decreased significantly (P<0.05). After the azithromycin treatment, the 24 h urine protein was decreased significantly (P<0.05), while the Ccr was increased significantly (P<0.05) compared with ADR+BSA group.

Conclusion: Azithromycin has a protective effects on the renal damage induced by doxorubicin and albumin in mice.

MeSH terms

  • Albumins / adverse effects*
  • Animals
  • Azithromycin / pharmacology*
  • Doxorubicin / adverse effects*
  • Kidney Diseases / chemically induced
  • Kidney Diseases / drug therapy*
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Random Allocation

Substances

  • Albumins
  • Doxorubicin
  • Azithromycin